[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Protagonist Therapeutics, Inc (PTGX)
Protagonist Therapeutics (PTGX) stock surges near 52-week high amid positive clinical trial data for icotrokinra and speculation of a Johnson & Johnson acquisition. Increased social media buzz and trading volume highlight growing investor interest.
About Protagonist Therapeutics, Inc
Protagonist Therapeutics, Inc. is a biotechnology company focused on developing novel peptide-based therapeutics.
Protagonist Therapeutics, Inc uses the ticker $PTGX for trading. Listed in the Stocks category within the Healthcare sectors.
Insights
- Protagonist Therapeutics, Inc (PTGX) trading volume hit $121.4M which is XXX% higher than it's daily average.
- Protagonist Therapeutics, Inc (PTGX) mentions hit XXX which is XXX% higher than it's daily average.
- Protagonist Therapeutics, Inc (PTGX) creators hit XXX which is XXX% higher than it's daily average.
- Protagonist Therapeutics, Inc (PTGX) social dominance hit XXXXXX which is XXX% higher than it's daily average.
- Protagonist Therapeutics, Inc (PTGX) trading volume is up XXXXXX% from the previous week.
- Protagonist Therapeutics, Inc (PTGX) social dominance is up XXXXXX% from the previous X months.
- Protagonist Therapeutics, Inc Price hit a 52-Week high of $XXXXX for the hour
- Protagonist Therapeutics, Inc Price hit an all time of $XXXXX for the hour
Price: $XXXXX
Price 24-Hour Time-Series Raw Data
The stock price is near a 52-week high, driven by positive clinical trial results for icotrokinra, increased social engagement, and speculation about a potential acquisition by Johnson & Johnson, leading to higher trading volumes.
24-Hour: XXXX% 7-Day: XXXX% 30-Day: XXXXX%
1-Year High: $XXXXX on 2025-12-12
1-Year Low: $XXXXX on 2025-02-25
AltRank: XXX
AltRank 24-Hour Time-Series Raw Data
Protagonist Therapeutics, Inc (PTGX) is currently AltRank #193 based on combined combined social and market metrics
Daily Average: XXX
X Week: XXX +65
X Month: XXX -XX
X Months: XXX -XXX
1-Year High: XXXXX on 2025-08-07
1-Year Low: XX on 2025-10-10
Galaxy Score: XX
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XX
X Week: XX +4
X Month: XX +20
X Months: XX +15
1-Year High: XX on 2025-03-10
1-Year Low: XX on 2025-08-01
Engagements: XXXXXX (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXXX
Daily Average: XXXXXX
X Week: XXXXXXX -XX%
X Month: XXXXXXXXX -XX%
X Months: XXXXXXXXXX +1,106%
X Year: XXXXXXXXXX +1,099%
1-Year High: XXXXXXXXX on 2025-11-01
1-Year Low: XXX on 2025-08-01
Engagements by network (24h): Reddit: XXX TikTok: XXXXX X: XXXXXX YouTube: XXXXXX
Mentions: XXX (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XX
X Week: XXX +5.10%
X Month: XXXXX -XXXX%
X Months: XXXXX +573%
X Year: XXXXX +856%
1-Year High: XXX on 2025-06-28
1-Year Low: XX on 2025-02-04
Mentions by network (24h): Reddit: XX TikTok: XXX X: XXX YouTube: XXX
Creators: XXX (24h)
Creators 24-Hour Time-Series Raw Data
XXX unique social accounts have posts mentioning Protagonist Therapeutics, Inc (PTGX) in the last XX hours which is up XX% from XXX in the previous XX hours
Daily Average: XX
X Week: XXX -XXXX%
X Month: XXXXX -XX%
X Months: XXXXX +995%
X Year: XXXXX +1,238%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-01-28
The most influential creators that mention Protagonist Therapeutics, Inc in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @doepke_michel | X | XXXXX | XX | XXXXXX |
| @semodough | X | XXXXXX | XX | XXXXXX |
| @joseiltondutradetudoumpouco | X | XXXXX | X | XXX |
| @bioinvestor24 | X | XXXXX | X | XXX |
| @SteveDJacobs | X | XXXXX | X | XXX |
| @protocolrecordings | X | XXXXXXX | X | XXX |
| @Biotech2k1 | X | XXXXXX | XX | XXX |
| @AponiaAnalytics | X | XXXXX | X | XXX |
| @RudyResearch | X | XXX | X | XXX |
| @marcelianonline | XX | XXXXXXX | X | XXX |
Sentiment: XX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% +3%
X Month: XX% +6%
X Months: XX% -XX%
X Year: XX% -XX%
1-Year High: XXX% on 2024-12-13
1-Year Low: XX% on 2025-01-01
Most Supportive Themes:
- Positive Clinical Trial Results: (40%) Protagonist Therapeutics announced positive clinical trial results for icotrokinra, a novel peptide-based therapeutic for psoriasis.
- Increased Trading Volume and Social Activity: (35%) Significant increases in trading volume, social dominance, and engagements indicate heightened market interest and community interaction.
- Analyst Recommendations and Price Targets: (15%) Analyst ratings and price targets suggest potential upside, contributing to positive sentiment and investor confidence.
Most Critical Themes:
- Market Volatility and General Market Sentiment: (10%) Overall market sentiment is neutral, with some discussions acknowledging general market volatility.
Social Dominance: XXXXX%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: XXXXX%
X Week: XXXXX% +0.041%
X Month: XXXXX% +0.006%
X Months: XXXXX% +0.022%
X Year: XXXXX% +0.017%
1-Year High: XXXX% on 2025-03-11
1-Year Low: XXXXX% on 2025-09-07
Market Dominance: XXXXXXX%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-11-26
1-Year Low: XXXXXXX% on 2025-03-17
Market Cap: $XXXXXXXXXXXXX
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXX +$5.90%
X Month: $XXXXXXXXXXXXX +$12%
X Months: $XXXXXXXXXXXXX +$71%
1-Year High: $XXXXXXXXXXXXX on 2025-12-12
1-Year Low: $XXXXXXXXXXXXX on 2025-02-27
Top Protagonist Therapeutics, Inc Social Posts
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"@WallStSai $JNJ will get either $PTGX or $ABVX. They will not spent $XX B on IBD"
X Link @bioinvestor24 2025-12-12T21:30Z 4896 followers, XXX engagements
"Jeffrey Epstein's ex-girlfriend accuses Republicans White House of prot. via @YouTube"
X Link @Lollybrewster 2025-12-12T19:04Z XXX followers, XXX engagements
"$PTGX next pipeline candidate Anyday Oral hepcidin developmental candidate announcement (Q4:2025) - could slip into #JPM26"
X Link @semodough 2025-12-12T17:48Z 41.9K followers, 3285 engagements
"Citizens reiterated $PTGX Market Outperform/$102. $TAK $JNJ Citizens said in its note: PTGX has a big decision coming up by mid-2026 when management has to determine whether to opt out of its 50/50 U.S. profit/loss share for rusfertide with Takeda which would change PTGX's downstream economics. We assume PTGX will opt out to bring in more risk-free cash that the company can deploy to advance its earlier-stage internal pipeline"
X Link @Quantumup1 2025-12-12T12:46Z 3932 followers, 4318 engagements